Pretransplant soluble CD30 serum concentration does not affect kidney graft outcomes 3 years after transplantation.
AuthorsKovac J, Arnol M, Vidan Jeras B, Bren AF, Kandus A,
JournalTransplant Proc
PubMed ID21168622
An elevated serum concentration of soluble the form of CD30 (sCD30), an activation marker of mainly T(H)2-type cytokines producing T lymphocytes, has been reported as a predictive factor for acute cellular rejection episodes and poor graft outcomes in kidney transplantation. This historic cohort study investigated the association of a pretransplant ... More